Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Digital Drug Discovery Company Wins A.I. Competition

Full data screen

A company using artificial intelligence algorithms and big data analytics to discover drug targets from RNA splicing errors is the winner of a competition among start-up enterprises for innovative uses of A.I. technology. . . . → Read More: Digital Drug Discovery Company Wins A.I. Competition

Cellectis, Wyss Inst. Partner on Recoding Human Genome

DNA puzzle

A bioengineering center at Harvard University and a biotechnology company are creating a process for genetically editing human cell lines to produce virus-resistant synthetic proteins for research and therapies. . . . → Read More: Cellectis, Wyss Inst. Partner on Recoding Human Genome

Platform to Integrate Robotics, Synthetic Biology, A.I.

Microbes

Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology. . . . → Read More: Platform to Integrate Robotics, Synthetic Biology, A.I.

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

Cough Suppressant Produced from Engineered Yeast Cells

A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells

Antibodies Licensed for Multi-Target Immunotherapies

MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies

RNA Treatment Tested for West Nile Virus

A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage. . . . → Read More: RNA Treatment Tested for West Nile Virus

Crowdsourced Project Building Whole Beta Cell Model

A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas. . . . → Read More: Crowdsourced Project Building Whole Beta Cell Model

Crispr Enhanced to Find, Edit Tiny Mutations

A bioengineering lab at Harvard University designed a refinement for genome editing to identify and remove small genetic mutations that can lead to diseases or organisms resistant to current drugs. . . . → Read More: Crispr Enhanced to Find, Edit Tiny Mutations